Second, while elderly AML patients exhibit increased prevalence of adverse cytogenetic and molecular profiles – including complex karyotypes and mutations in TP53 and DNMT3A – the limited subgroup sample sizes precluded meaningful stratification by genomic features. The gene discussed is TP53; the disease is acute myeloid leukemia.